An important whitepaper explores how the Welch Allyn RetinaVue care delivery model is shifting the paradigm in diabetic retinopathy care,1 by lowering the cost2 and improving the accessibility3 of diabetic retinopathy exams. Diabetic retinopathy programs, like the RetinaVue care delivery model, enable early detection2 in primary care settings to help close diabetes care gaps,4 increase HEDIS quality scores,4 and reduce healthcare costs.2
Visual outcomes for patients with diabetic retinopathy are always going to be better if diabetic retinopathy is identified early.
DR. Edward Chaum, M.D., PH.D.
Download to learn about the model that helps preserve vision.
Please fill out this form to get the important details - and a leading ophthalmologist's perspective - on how the RetinaVue care delivery model can make the early detection of diabetic retinopathy affordable5, improve quality measures4 and close diabetes care gaps.4

References
- Baxter. Early Detection Of Diabetic Retinopathy In Primary Care Settings: A New Model for Preserving Vision in Patients Living with Diabetes. US-FLC147-230075-V2.
- Newman, M. (2009) Fiscal Impact of AB 175: Analysis of the Cost Effectiveness of Store and Forward Teleophthalmology, Blue Sky Consulting Group for California Health Care Foundation, www.chcf.org/wp-content/uploads/2017/12/PDF-FiscalImpactAB175AnalysisTeleophthalmology.pdf
- Liu Y, Swearingen R. Diabetic eye screening: knowledge and perspectives from providers and patients. Curr Diab Rep. 2017 Aug 31; 17(10):94.
- Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health. 2013 Dec; 19(12): 942-8.
- Cuadros J, Bresnick G. Can commercially available handheld retinal cameras effectively screen diabetic retinopathy? J Diabetes Sci Technol. 2017 Jan; 11(1):135-7.
Rx Only. For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.
Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
HEDIS is a trademark of the National Committee for Quality Assurance (NCQA).